← Back
$BIOA All transactions

BioAge Labs, Inc.

▼ SELL 10b5-1 Plan

$ Value

$4.2M

Shares

233,107

Price

$18

Filed

Jan 15

Insider

Name

Fortney Kristen

Title

Chief Executive Officer

CIK

0002032751

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-13

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

976,949

Footnotes

The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.385 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Filing Info

Accession No.

0002032751-26-000003

Form Type

4

Issuer CIK

0001709941

Fortney Kristen's History

Date Ticker Type Value
2026-02-17 BIOA A $0
2026-01-13 BIOA $4.2M

Other Insiders at BIOA (90d)

Insider Bought Sold Last
GOLDSTEIN DOV A MD
Chief Financial Officer
2026-03-01
RUBIN PAUL D
Chief Medical Officer
$447K 2026-04-01
Barton Shane
Principal Accounting Officer
2026-02-17
Fortney Kristen
Chief Executive Officer
2026-02-17
Morgen Eric
Chief Operating Officer
2026-02-17